HK:9969 Stock Latest News
Company AnnouncementsInnoCare Pharma Issues Unaudited Q3 2026 Report Under PRC Accounting Rules1w ago
Company AnnouncementsInnoCare Pharma Sets Board Meeting to Approve Q3 2026 Results3w ago
Company AnnouncementsInnoCare Pharma Strikes Multibillion-Dollar Drug Discovery Pact With Eli Lilly1M ago
Company AnnouncementsInnoCare Pharma Signals Profitable Shift in 20262M ago
Company AnnouncementsInnoCare Pharma Swings to Profit on Surging Drug Sales and New Launches2M ago
Company AnnouncementsInnoCare Pharma Sets Board Meeting to Approve 2026 Interim Results2M agoCompany AnnouncementsInnoCare’s Oral Psoriasis Drug ICP‑488 Hits Phase III Target, Paving Path to Regulatory Filing3M ago
Company AnnouncementsInnoCare’s TYK2 Inhibitor Soficitinib Delivers Positive Phase II Results in Non-Segmental Vitiligo3M ago
Company AnnouncementsInnoCare’s TYK2 Inhibitor Soficitinib Hits Phase III Goal in Atopic Dermatitis3M ago
Company AnnouncementsInnoCare Pharma Grants Performance-Linked RSUs Under 2023 Share Award Scheme4M ago
Company AnnouncementsInnoCare Shareholders Approve All Resolutions at 2026 AGM4M ago- Company AnnouncementsInnoCare Pharma Launches 2026 RMB Share Incentive Scheme with First Grant of Restricted Shares4M ago
Company AnnouncementsInnoCare Pharma Names New Joint Company Secretary and Secures Listing Rules Waiver5M ago
Company AnnouncementsInnoCare Wins Australian Approval for Lymphoma Drug Orelabrutinib5M ago
Company AnnouncementsInnoCare Starts First-in-Human Trial of Oral IL-17 Inhibitor ICP-0545M ago- Company AnnouncementsInnoCare Pharma Sets 2026 AGM to Approve 2025 Results and Renew Share Issuance Mandate6M ago
- Company AnnouncementsInnoCare Pharma Grants RSUs Tied to Revenue and R&D Milestones6M ago
Company AnnouncementsInnoCare Pharma Seeks Approval for 2026 RMB Share Incentive Scheme and Wins HKEX Waiver6M ago